300482 万孚生物
已收盘 08-14 15:00:00
资讯
新帖
简况
万孚生物:8月6日董事王继华增持股份合计41.05万股
证券之星 · 08-07
万孚生物:8月6日董事王继华增持股份合计41.05万股
万孚生物获得外观设计专利授权:“体外诊断设备”
证券之星 · 08-07
万孚生物获得外观设计专利授权:“体外诊断设备”
万孚生物控股股东增持115.6万股公司股份
北京商报 · 08-06
万孚生物控股股东增持115.6万股公司股份
万孚生物:8月5日董事王继华增持股份合计51.75万股
证券之星 · 08-06
万孚生物:8月5日董事王继华增持股份合计51.75万股
万孚生物:控股股东王继华增持计划实施完成 增持金额2004.41万元
格隆汇 · 08-06
万孚生物:控股股东王继华增持计划实施完成 增持金额2004.41万元
万孚生物:8月4日董事王继华增持股份合计22.8万股
证券之星 · 08-05
万孚生物:8月4日董事王继华增持股份合计22.8万股
万孚生物(300482)披露控股股东增持公司股份计划公告,7月28日股价上涨0.56%
证券之星 · 07-28
万孚生物(300482)披露控股股东增持公司股份计划公告,7月28日股价上涨0.56%
万孚生物(300482.SZ)拟3000万元至6000万元回购公司股份
智通财经 · 07-28
万孚生物(300482.SZ)拟3000万元至6000万元回购公司股份
万孚生物(300482)披露万孚转债即将到期暨停止交易提示性公告,7月27日股价上涨2.49%
证券之星 · 07-27
万孚生物(300482)披露万孚转债即将到期暨停止交易提示性公告,7月27日股价上涨2.49%
万孚生物(300482)披露2026年第二季度可转换公司债券转股情况,7月2日股价下跌0.82%
证券之星 · 07-02
万孚生物(300482)披露2026年第二季度可转换公司债券转股情况,7月2日股价下跌0.82%
股市必读:万孚生物(300482)6月17日董秘有最新回复
证券之星 · 06-18
股市必读:万孚生物(300482)6月17日董秘有最新回复
万孚生物涨9.45%,信达证券一个月前给出“买入”评级
证券之星 · 06-16
万孚生物涨9.45%,信达证券一个月前给出“买入”评级
万孚生物涨15.54%,信达证券一个月前给出“买入”评级
证券之星 · 06-09
万孚生物涨15.54%,信达证券一个月前给出“买入”评级
万孚生物涨15.06%,信达证券四周前给出“买入”评级
证券之星 · 06-05
万孚生物涨15.06%,信达证券四周前给出“买入”评级
万孚生物(300482)披露万孚转债恢复转股提示性公告,6月2日股价下跌1.02%
证券之星 · 06-02
万孚生物(300482)披露万孚转债恢复转股提示性公告,6月2日股价下跌1.02%
万孚生物(300482)披露2025年年度权益分派实施公告,5月25日股价上涨0.22%
证券之星 · 05-25
万孚生物(300482)披露2025年年度权益分派实施公告,5月25日股价上涨0.22%
万孚生物:公司U-Card DX200配套的微流控芯片系公司自主设计开发及生产
证券之星 · 05-22
万孚生物:公司U-Card DX200配套的微流控芯片系公司自主设计开发及生产
万孚生物(300482)披露关于实施权益分派期间万孚转债暂停转股的提示性公告,5月21日股价下跌1.05%
证券之星 · 05-21
万孚生物(300482)披露关于实施权益分派期间万孚转债暂停转股的提示性公告,5月21日股价下跌1.05%
万孚生物(300482)披露2025年年度股东会会议决议公告,5月18日股价下跌2.21%
证券之星 · 05-18
万孚生物(300482)披露2025年年度股东会会议决议公告,5月18日股价下跌2.21%
万孚生物涨6.22%,信达证券五日前给出“买入”评级
证券之星 · 05-11
万孚生物涨6.22%,信达证券五日前给出“买入”评级
暂无数据
公司概况
公司名称:
广州万孚生物技术股份有限公司
所属行业:
医药制造业
上市日期:
2015-06-30
主营业务:
广州万孚生物技术股份有限公司的主营业务是快速诊断试剂及配套仪器的研发、生产智造、营销及服务。公司的主要产品是传染病检测、慢性疾病检测、妊娠及优生优育检测、毒品(药物滥用)检测。2025年,公司注册获证专利工作实现重大突破,全年共获得产品注册证合计66个,其中NMPA获证51个,CE获证8个,FDA获证4个,MDALL获证3个。新增专利授权33件,累计授权有效专利504件(其中发明专利151件,实用新型专利260件,外观设计93件)。
发行价格:
16.00
{"stockData":{"symbol":"300482","market":"SZ","secType":"STK","nameCN":"万孚生物","latestPrice":17.5,"timestamp":1786691001000,"preClose":17.72,"halted":0,"volume":6685037,"delay":0,"changeRate":-0.0124,"floatShares":430000000,"shares":468000000,"eps":-0.3584,"marketStatus":"已收盘","change":-0.22,"latestTime":"08-14 15:00:00","open":17.72,"high":18.02,"low":17.4,"amount":118000000,"amplitude":0.035,"askPrice":17.51,"askSize":226,"bidPrice":17.5,"bidSize":1105,"shortable":0,"etf":0,"ttmEps":-0.3584,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786930200000},"marketStatusCode":5,"adr":0,"adjPreClose":17.72,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":19.49,"lowLimit":15.95,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":468088839,"isCdr":false,"pbRate":1.53,"roa":"--","roe":"1.54%","epsLYR":-0.13,"committee":0.662752,"marketValue":8192000000,"turnoverRate":0.0155,"status":1,"floatMarketCap":7526000000},"requestUrl":"/m/hq/s/300482/tweets","defaultTab":"tweets","newsList":[{"id":"2657264624","title":"万孚生物:8月6日董事王继华增持股份合计41.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657264624","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657264624?lang=zh_cn&edition=full","pubTime":"2026-08-07 21:01","pubTimestamp":1786107692,"startTime":"0","endTime":"0","summary":"证券之星消息,根据8月7日市场公开信息、上市公司公告及交易所披露数据整理,万孚生物(300482)最新董监高及相关人员股份变动情况:2026年8月6日公司董事王继华共增持公司股份41.05万股,占公司总股本为0.0877%。变动期间公司股价下跌1.04%,8月6日当日收盘报17.12元。万孚生物近半年内的董监高及核心技术人员增减持详情如下:万孚生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出1269.47万,融资余额减少;融券净流出11.08万,融券余额减少。该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、万孚生物公告,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700038937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","300482","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652806","title":"万孚生物获得外观设计专利授权:“体外诊断设备”","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652806","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657652806?lang=zh_cn&edition=full","pubTime":"2026-08-07 03:26","pubTimestamp":1786044415,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示万孚生物新获得一项外观设计专利授权,专利名为“体外诊断设备”,专利申请号为CN202530777215.3,授权日为2026年8月7日。今年以来万孚生物新获得专利授权33个,较去年同期增加了153.85%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700004410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0197","BK0239","300482"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657658289","title":"万孚生物控股股东增持115.6万股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2657658289","media":"北京商报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657658289?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:27","pubTimestamp":1786026420,"startTime":"0","endTime":"0","summary":"8月6日晚间,万孚生物(300482)披露公告称,控股股东、实际控制人王继华通过深交所集中竞价交易方式增持公司股份115.6万股,约占公司总股本的0.25%,增持金额约为2004.41万元,本次增持计划已实施完毕。据此前公告,王继华计划以其自有资金或自筹资金通过集中竞价方式增持公司股份,增持金额为2000万元至4000万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-06/doc-inimkwtf0537950.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-06/doc-inimkwtf0537950.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","300482","BK0046","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657634251","title":"万孚生物:8月5日董事王继华增持股份合计51.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657634251","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657634251?lang=zh_cn&edition=full","pubTime":"2026-08-06 21:01","pubTimestamp":1786021284,"startTime":"0","endTime":"0","summary":"证券之星消息,根据8月6日市场公开信息、上市公司公告及交易所披露数据整理,万孚生物最新董监高及相关人员股份变动情况:2026年8月5日公司董事王继华共增持公司股份51.75万股,占公司总股本为0.1106%。万孚生物近半年内的董监高及核心技术人员增减持详情如下:万孚生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出1323.19万,融资余额减少;融券净流出11.89万,融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600037945.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0197","300482"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657633546","title":"万孚生物:控股股东王继华增持计划实施完成 增持金额2004.41万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657633546","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657633546?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:21","pubTimestamp":1786015289,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0046","BK0239","BK0197","300482"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657479805","title":"万孚生物:8月4日董事王继华增持股份合计22.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657479805","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657479805?lang=zh_cn&edition=full","pubTime":"2026-08-05 21:01","pubTimestamp":1785934881,"startTime":"0","endTime":"0","summary":"证券之星消息,根据8月5日市场公开信息、上市公司公告及交易所披露数据整理,万孚生物最新董监高及相关人员股份变动情况:2026年8月4日公司董事王继华共增持公司股份22.8万股,占公司总股本为0.0487%。万孚生物近半年内的董监高及核心技术人员增减持详情如下:万孚生物的高管列表及最新持股情况如下:融资融券数据显示该股近5日融资净流出2354.25万,融资余额减少;融券净流出7.42万,融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500041678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300482","BK0197","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654588318","title":"万孚生物(300482)披露控股股东增持公司股份计划公告,7月28日股价上涨0.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654588318","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654588318?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:40","pubTimestamp":1785249630,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘,万孚生物报收于16.17元,较前一交易日上涨0.56%,最新总市值为75.69亿元。万孚生物于近日披露《关于控股股东、实际控制人增持公司股份计划的公告》。公告显示,公司控股股东、实际控制人王继华女士计划自公告披露之日起3个月内,以自有或自筹资金通过集中竞价方式增持公司股份,增持金额不低于2,000万元且不超过4,000万元。王继华女士目前直接持有公司10.6%股份,与配偶合计持有31.5%。增持期间及法定期限内不减持所持股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800040141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0197","BK0239","300482"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654072738","title":"万孚生物(300482.SZ)拟3000万元至6000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2654072738","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654072738?lang=zh_cn&edition=full","pubTime":"2026-07-28 16:39","pubTimestamp":1785227958,"startTime":"0","endTime":"0","summary":"智通财经APP讯,万孚生物(300482.SZ)发布公告,公司拟使用自有资金以集中竞价交易方式回购部分公司股份,回购股份的资金总额不低于人民币3,000万元(含)且不超过人民币6,000万元(含)进行回购,回购股份的价格区间不超过人民币27.06元/股(含)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1473072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300482","BK0239","BK0046","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654046864","title":"万孚生物(300482)披露万孚转债即将到期暨停止交易提示性公告,7月27日股价上涨2.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654046864","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654046864?lang=zh_cn&edition=full","pubTime":"2026-07-27 22:22","pubTimestamp":1785162141,"startTime":"0","endTime":"0","summary":"截至2026年7月27日收盘,万孚生物报收于16.08元,较前一交易日上涨2.49%,最新总市值为75.27亿元。该股当日开盘15.52元,最高16.12元,最低15.47元,成交额达1.15亿元,换手率为1.68%。近日,广州万孚生物技术股份有限公司发布公告,提醒“万孚转债”即将到期。最后交易日为2026年8月26日,自8月27日起停止交易。截至8月31日收市后仍未转股的债券将被强制赎回并摘牌。停止交易后至转股期结束前,持有人仍可转股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700034913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0197","BK0239","300482"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648506565","title":"万孚生物(300482)披露2026年第二季度可转换公司债券转股情况,7月2日股价下跌0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648506565","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648506565?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:47","pubTimestamp":1782985640,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘,万孚生物报收于17.03元,较前一交易日下跌0.82%,最新总市值为79.72亿元。该股当日开盘17.11元,最高17.86元,最低16.98元,成交额达1.79亿元,换手率为2.41%。近日,广州万孚生物技术股份有限公司披露《关于2026年第二季度可转换公司债券转股情况的公告》。公告同时列示了历次转股价格调整情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200030331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0197","BK0046","300482"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644572332","title":"股市必读:万孚生物(300482)6月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644572332","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644572332?lang=zh_cn&edition=full","pubTime":"2026-06-18 01:37","pubTimestamp":1781717830,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘,万孚生物报收于20.22元,下跌2.46%,换手率5.09%,成交量21.89万手,成交额4.41亿元。董秘最新回复投资者: 请你们及时回复邮箱中投资者关于股东人数的问题,谢谢,公司的对外电话是02032215701吗董秘: 尊敬的投资者您好,您的咨询已回复,请注意查收,感谢您的关注。当日关注点交易信息汇总:6月17日主力资金净流出2390.37万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800001435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","300482","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643712737","title":"万孚生物涨9.45%,信达证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2643712737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643712737?lang=zh_cn&edition=full","pubTime":"2026-06-16 16:41","pubTimestamp":1781599293,"startTime":"0","endTime":"0","summary":"今日万孚生物涨9.45%,收盘报20.73元。2026年5月6日,信达证券研究员唐爱金发布了对万孚生物的研报《26Q1迎经营拐点,国际化及新产品亮点突出》,该研报对万孚生物给出“买入”评级。研报中预计公司2026-2028年营业收入分别为25.13、28.91、33.35亿元,同比增速分别为20.4%、15.0%、15.4%,实现归母净利润为3.91、4.67、5.63亿元,同比分别增长719.9%、19.4%、20.6%,对应PE分别为22、18、15倍,维持“买入”评级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600029078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300482","601059"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642783463","title":"万孚生物涨15.54%,信达证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2642783463","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642783463?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:52","pubTimestamp":1780995129,"startTime":"0","endTime":"0","summary":"今日万孚生物涨15.54%,收盘报20.45元。2026年5月6日,信达证券研究员唐爱金发布了对万孚生物的研报《26Q1迎经营拐点,国际化及新产品亮点突出》,该研报对万孚生物给出“买入”评级。研报中预计公司2026-2028年营业收入分别为25.13、28.91、33.35亿元,同比增速分别为20.4%、15.0%、15.4%,实现归母净利润为3.91、4.67、5.63亿元,同比分别增长719.9%、19.4%、20.6%,对应PE分别为22、18、15倍,维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900027325.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300482","601059"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641502116","title":"万孚生物涨15.06%,信达证券四周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2641502116","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641502116?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:44","pubTimestamp":1780649046,"startTime":"0","endTime":"0","summary":"今日万孚生物涨15.06%,收盘报18.49元。2026年5月6日,信达证券研究员唐爱金发布了对万孚生物的研报《26Q1迎经营拐点,国际化及新产品亮点突出》,该研报对万孚生物给出“买入”评级。研报中预计公司2026-2028年营业收入分别为25.13、28.91、33.35亿元,同比增速分别为20.4%、15.0%、15.4%,实现归母净利润为3.91、4.67、5.63亿元,同比分别增长719.9%、19.4%、20.6%,对应PE分别为22、18、15倍,维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300482","601059"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640911192","title":"万孚生物(300482)披露万孚转债恢复转股提示性公告,6月2日股价下跌1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640911192","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640911192?lang=zh_cn&edition=full","pubTime":"2026-06-02 17:48","pubTimestamp":1780393691,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘,万孚生物报收于17.41元,较前一交易日下跌1.02%,最新总市值为81.49亿元。该股当日开盘17.65元,最高17.74元,最低17.39元,成交额达6566.04万元,换手率为0.87%。近日,广州万孚生物技术股份有限公司发布公告,公司可转换公司债券“万孚转债”因实施2025年度权益分派,自2026年5月22日至2026年6月1日暂停转股。根据规定,将于权益分派股权登记日后的第一个交易日,即2026年6月2日起恢复转股。公司提醒债券持有人注意相关安排。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200035018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300482","BK0239","BK0046","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638556552","title":"万孚生物(300482)披露2025年年度权益分派实施公告,5月25日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638556552","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638556552?lang=zh_cn&edition=full","pubTime":"2026-05-25 22:44","pubTimestamp":1779720258,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘,万孚生物报收于17.99元,较前一交易日上涨0.22%,最新总市值为84.21亿元。该股当日开盘18.1元,最高18.44元,最低17.97元,成交额达7553.69万元,换手率为0.97%。公司于近日披露《2025年年度权益分派实施公告》。股权登记日为2026年6月1日,除权除息日为2026年6月2日。A股股东现金红利由托管证券公司划入资金账户,部分股东由公司自行派发。本次权益分派实施后,可转债转股价格将相应调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500034255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0046","300482","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637251362","title":"万孚生物:公司U-Card DX200配套的微流控芯片系公司自主设计开发及生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2637251362","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637251362?lang=zh_cn&edition=full","pubTime":"2026-05-22 11:33","pubTimestamp":1779420831,"startTime":"0","endTime":"0","summary":"证券之星消息,万孚生物05月21日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘好,U-Card DX200仅是检测仪器。此前海外参股布局相关实动作进展如何?万孚生物回复:尊敬的投资者您好,公司U-Card DX200配套的微流控芯片系公司自主设计开发及生产。目前公司已有U-CardDx 200完整的自研微流控芯片体系,而且核心耗材皆为国内供应链,感谢您的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200019194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300482","BK0197","159813","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637384220","title":"万孚生物(300482)披露关于实施权益分派期间万孚转债暂停转股的提示性公告,5月21日股价下跌1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637384220","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637384220?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:07","pubTimestamp":1779358036,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘,万孚生物报收于17.92元,较前一交易日下跌1.05%,最新总市值为83.88亿元。该股当日开盘18.12元,最高18.29元,最低17.88元,成交额达9037.37万元,换手率为1.16%。近日,广州万孚生物技术股份有限公司发布《关于实施权益分派期间万孚转债暂停转股的提示性公告》。公告显示,因实施2025年度权益分派,可转换公司债券“万孚转债”自2026年5月22日起至权益分派股权登记日止暂停转股,恢复转股时间为股权登记日后的第一个交易日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300482","BK0046","BK0197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636747021","title":"万孚生物(300482)披露2025年年度股东会会议决议公告,5月18日股价下跌2.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636747021","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636747021?lang=zh_cn&edition=full","pubTime":"2026-05-18 17:53","pubTimestamp":1779097994,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘,万孚生物报收于18.17元,较前一交易日下跌2.21%,最新总市值为85.05亿元。该股当日开盘18.58元,最高18.78元,最低18.02元,成交额达9231.02万元,换手率为1.18%。万孚生物近日披露《2025年年度股东会会议决议公告》。关联股东对关联交易及董事薪酬议案回避表决。出席会议股东共210人,代表股份占公司有表决权总股份的44.0206%。律师认为会议召集、召开及表决程序合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800028362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0239","300482","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634099954","title":"万孚生物涨6.22%,信达证券五日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2634099954","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634099954?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:37","pubTimestamp":1778488644,"startTime":"0","endTime":"0","summary":"今日万孚生物涨6.22%,收盘报20.32元。2026年5月6日,信达证券研究员唐爱金发布了对万孚生物的研报《26Q1迎经营拐点,国际化及新产品亮点突出》,该研报对万孚生物给出“买入”评级。研报中预计公司2026-2028年营业收入分别为25.13、28.91、33.35亿元,同比增速分别为20.4%、15.0%、15.4%,实现归母净利润为3.91、4.67、5.63亿元,同比分别增长719.9%、19.4%、20.6%,对应PE分别为22、18、15倍,维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100022168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601059","300482"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786706478375,"stockEarnings":[{"period":"1week","weight":0.035},{"period":"1month","weight":0.0504},{"period":"3month","weight":-0.0344},{"period":"6month","weight":-0.1083},{"period":"1year","weight":-0.2677},{"period":"ytd","weight":-0.0916}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州万孚生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41957人(较上一季度增加3.24%)","perCapita":"10250股","listingDate":"2015-06-30","address":"广东省广州市黄埔区科学城荔枝山路8号","registeredCapital":"46808万元","survey":" 广州万孚生物技术股份有限公司的主营业务是快速诊断试剂及配套仪器的研发、生产智造、营销及服务。公司的主要产品是传染病检测、慢性疾病检测、妊娠及优生优育检测、毒品(药物滥用)检测。2025年,公司注册获证专利工作实现重大突破,全年共获得产品注册证合计66个,其中NMPA获证51个,CE获证8个,FDA获证4个,MDALL获证3个。新增专利授权33件,累计授权有效专利504件(其中发明专利151件,实用新型专利260件,外观设计93件)。","listedPrice":16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万孚生物(300482)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万孚生物(300482)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万孚生物,300482,万孚生物股票,万孚生物股票老虎,万孚生物股票老虎国际,万孚生物行情,万孚生物股票行情,万孚生物股价,万孚生物股市,万孚生物股票价格,万孚生物股票交易,万孚生物股票购买,万孚生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万孚生物(300482)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万孚生物(300482)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}